FCFrancesco Cei

Francesco Cei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francesco Cei has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Artificial intelligence in robotic urologic surgery: a scoping review

    by Francesco Cei, Hossein Arang, Ethan Layne, Conner Ganjavi, Severin Rodler, Edoardo Beatrici, Pieter De Backer, Ruben De Groote, Geert De Naeyer, Alexandre Mottrie, et al.

    Background and aim Artificial intelligence (AI) is increasingly being integrated into robotic urologic surgery. However, existing literature remains fragmented across different technological domains. This scoping review aimed to systematically map and synthesize current evidence on AI applications within robotic urologic surgery, identifying principal domains, clinical relevance, and existing limitations. Evidence acquisition A scoping review was conducted according to PRISMA-ScR guidelines. PubMed and Web of Science were searched for English-language peer-reviewed studies published between 2018 and 2024. Studies were included if they evaluated AI applications integrated into the robotic surgical workflow (computer vision, augmented reality, cognitive analytics, skill assessment, or outcomes prediction). Reviews, editorials, and non-robotic applications were excluded. Evidence synthesis Of 256 records identified, 47 met the inclusion criteria. Applications were distributed across five domains: computer vision (19%), augmented reality and navigation (15%), AI-driven objective skill assessment (30%), cognitive analytics (17%), and surgical outcomes prediction (19%). Most studies were single-center feasibility investigations. Computer vision demonstrated high technical accuracy for instrument and gesture recognition, while AI-based performance metrics showed emerging associations with clinically relevant outcomes. Augmented reality systems improved anatomical visualization and surgical planning, and cognitive analytics explored real-time workload assessment. Conclusion AI in robotic urologic surgery is predominantly focused on assistive and analytical applications, particularly intraoperative image analysis and objective performance assessment. While early evidence suggests technical feasibility and potential clinical value, most systems remain investigational. Robust multicenter validation, workflow integration, and governance frameworks addressing accountability and data management are required before routine clinical implementation.

  • Open Access

    Intraoperative margin assessment using fluorescence confocal microscopy during robot‐assisted radical prostatectomy: a first experience

    by Mario de Angelis, Edoardo Beatrici, Natali Rodriguez Penaranda, Nicola Frego, Stefano Resca, Enrico Vecchio, Attilio Barretta, Marco Ticonosco, Claudio Brancelli, Vincenzo Cavarra, et al.

    Objective: To evaluate the feasibility of adopting fluorescence confocal microscopy (FCM) for intraoperative assessment of positive surgical margins (PSMs) during robot‐assisted radical prostatectomy (RARP) in a real‐world clinical setting. Patients and Methods: We conducted a prospective observational study including consecutive patients undergoing RARP between October 2023 and November 2024 in whom intraoperative margin assessment was performed using FCM (Histolog® Scanner; SamanTree Medical SA, Lausanne, Switzerland). After exclusion of initial learning‐curve cases and non‐interpretable scans, a per‐patient analysis was performed. Prostate specimens were scanned ex vivo intraoperatively, and digital images were reviewed remotely and in real time by an experienced uropathologist blinded to final pathology. Final histopathological evaluation served as the reference standard. Diagnostic performance metrics included sensitivity, specificity, positive predictive value (PPV), negative PV (NPV), and overall accuracy, assessed both for any PSM and for clinically significant PSMs (≥3 mm). Results: A total of 101 patients were included in the final analysis. The median (interquartile range) overall time from prostate extraction to intraoperative report was 13 (6–16) min. At final pathology, 17 patients (17%) had PSMs. For detection of any PSM, FCM demonstrated a sensitivity of 88.2%, specificity of 91.7%, PPV of 68.2%, and NPV of 97.5%, with an overall diagnostic accuracy of 91.1%. When restricting the analysis to clinically significant PSMs (≥3 mm), diagnostic performance improved, with sensitivity, specificity, PPV, and NPV of 93.8%, 91.8%, 68.2%, and 98.7%, respectively, and an overall accuracy of 92.1%. Conclusions: Intraoperative surgical margin assessment using FCM is feasible and demonstrates good diagnostic accuracy compared with final histopathology, with rapid turnaround times compatible with routine surgical workflows. Diagnostic performance improves when clinically relevant PSM length thresholds are applied. Larger multicentre studies and randomised trials are warranted to determine whether FCM‐guided intraoperative decision‐making can improve oncological and functional outcomes after RARP.


  • Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy

    by Francesco Cei, Daniele Cignoli, Irene Franco, Koon Ho Rha, Christian Wagner, Alexander Kutikov, James Porter, Ben Challacombe, Ketan Badani, Eduard Roussel, et al.

    Objectives: To explore the effects of ischaemia time (IT) in a multicentre cohort of patients with solitary kidney (SK), treated with partial nephrectomy (PN) for a renal mass, on short‐ and long‐term kidney function, haemorrhagic risk and pathological outcomes. Methods: This is an observational study of 426 patients with SK treated with on‐ and off‐clamp PN for a single cT1–3 N0M0 renal mass from 2000 to 2023 at 19 global institutions. The primary outcomes were postoperative and 1‐year renal function. The secondary outcomes of the study were haemorrhagic risk, defined as estimated blood loss (EBL) and peri‐operative transfusions, and presence of positive surgical margins. The effect of IT and arterial clamping strategy was estimated using linear and logistic regressions for continuous and categorical outcomes, respectively. Results: On‐clamp PN was performed in 56% of patients ( n = 237). The median (interquartile range [IQR]) age, body mass index, preoperative estimated glomerular filtration rate (eGFR), clinical size and PADUA score were 65 (58–71) years, 27 (24–29) kg/m 2 , 58 (45–46) mL/min, 3 (2–4.2) cm and 8 (7–10), respectively. The median (IQR) duration of IT was 19 (13–25) min. In multivariable linear and logistic regression analyses (MVA), IT was not associated with decreased postoperative eGFR (estimate −0.08 mL/min; P = 0.3) or 1‐year eGFR (estimate −0.1 mL/min; P = 0.2). No association between on‐clamp strategy and eGFR decline was recorded either postoperatively (estimate −3.11 mL/min; P = 0.1) or at 1 year (estimate −3.12 mL/min; P = 0.1). The median (IQR) EBL was lower in the on‐clamp group at 200 (100–400) mL vs 300 (145–500) mL in the off‐clamp group. In MVA predicting haemorrhagic risk, arterial clamping was associated with lower risk of transfusions (odds ratio 0.45; P = 0.01). Conclusions: In patients with SK, on‐clamp PN did not affect long‐term renal function and was associated with a modestly lower need for peri‐operative transfusion. The routine use of the off‐clamp technique is therefore not supported by these findings, although its selective application may remain appropriate in cases with a high risk of renal function decline.


  • Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer: A Comparative Study of Depression and Sexual Function

    by Chiara Re, Alessandro Larcher, Francesco Cei, Federico Belladelli, Lucia Salerno, Floriana Iannace, Ludovica Cella, Attilio Barretta, Isaline Rowe, Francesca Corea, et al.

    PURPOSE: Von Hippel-Lindau (VHL) disease is a rare genetically inherited disorder and represents the most frequent cause of hereditary renal cancer (RC). Depression and quality of life (QoL) are often neglected or underreported issues in individuals affected by VHL disease. We sought to investigate QoL items in patients with VHL disease versus patients with sporadic RC (spRC) in a comparative analysis using patient-reported outcome measures (PROMs). MATERIALS AND METHODS: In an institutional prospective VHL program, 30 VHL patients with RC have been enrolled. The comparator was a cohort of 393 patients surgically treated for spRC. To prospectively evaluate PROMs about depression and sexual functioning, all patients completed the Beck Depression Inventory scale, the Female Sexual Function Index for female, and the International Index of Erectile Function for male patients, respectively. Multivariable linear regression analysis tested the association between VHL disease or spRC and the study outcomes. RESULTS: Overall, 30 (7%) and 393 (93%) patients had VHL disease and spRC, respectively. At multivariable linear regression analysis, patients with VHL disease were more prone to depression according to a higher Beck Depression Inventory score (estimate 8.8; P < .0001); this difference was more pronounced in older patients. Conversely, VHL and spRC groups did not differ in terms of sexual functioning. CONCLUSION: Patients diagnosed with hereditary RC are more prone to depression compared with patients diagnosed with spRC. Conversely, the two groups did not differ in terms of sexual well-being. These novel findings highlight the clinical importance of psychological counseling throughout the management workup of patients with lifelong hereditary disorders.

  • Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial

    by Conner Ganjavi, Ethan Layne, Francesco Cei, Karanvir Gill, Vasileios Magoulianitis, Andre Abreu, Mitchell Goldenberg, Mihir M. Desai, Inderbir Gill, Giovanni E. Cacciamani

    PURPOSE: To evaluate a generative artificial intelligence (GAI) framework for creating readable lay abstracts and summaries (LASs) of urologic oncology research, while maintaining accuracy, completeness, and clarity, for the purpose of assessing their comprehension and perception among patients and caregivers. METHODS: Forty original abstracts (OAs) on prostate, bladder, kidney, and testis cancers from leading journals were selected. LASs were generated using a free GAI tool, with three versions per abstract for consistency. Readability was compared with OAs using validated metrics. Two independent reviewers assessed accuracy, completeness, and clarity and identified AI hallucinations. A pilot study was conducted with 277 patients and caregivers randomly assigned to receive either OAs or LASs and complete comprehension and perception assessments. RESULTS: Mean GAI-generated LAS generation time was .05). Quality scores ranged from 85% to 100%, with hallucinations in 1% of sections. The best test showed significantly better readability (68.9 v 25.3; P < .001), grade level, and text metrics compared with the OA. Methods sections had slightly lower accuracy (85% v 100%; P = .03) and trifecta achievement (82.5% v 100%; P = .01), but other sections retained high quality (≥92.5%; P > .05). GAI-generated LAS recipients scored significantly better in comprehension and most perception-based questions ( P < .001) with LAS being the only consistently significant predictor ( P < .001). CONCLUSION: GAI-generated LASs for urologic oncology research are highly readable and generally preserve the quality of the OAs. Patients and caregivers demonstrated improved comprehension and more favorable perceptions of LASs compared with OAs. Human oversight remains essential to ensure the accurate, complete, and clear representations of the original research.


  • Biopsy‐all strategy in patients with a renal mass: simulation of a randomised controlled trial

    by Federico Belladelli, Giuseppe Rosiello, Lucia Salerno, Giacomo Musso, Francesco Cei, Chiara Re, Andrea Folcia, Giuseppe Fallara, Rayan Matloob, Nicholas Branger, et al.

    Objectives: To investigate the clinical benefit and cost‐effectiveness of a renal biopsy (RB)‐all strategy for patients with a renal mass, as in renal cancer the indication for upfront surgery (SUR) without previous RB invariably results in the overtreatment of patients with benign histology.Patients and Methods: A total of 1729 patients with clinical (c)T1–2 cM0 renal mass treated with SUR were included. To simulate a randomised clinical trial comparing patients who underwent SUR vs RB and subsequent treatment, a random binary variable assigned patients to Arm a‐SUR and Arm b‐RB. In Arm a‐SUR, patients are all treated with SUR; postoperative complications and costs are those recorded after surgery. In Arm b‐RB, we have assumed an 8–20% uncertain RB histology rate and a 0.07% RB‐related complication rate to build our simulation model. Patients are selected for RB and subsequently for surgery in case of malignant or uncertain RB histology; complications are those recorded after surgery in case of malignant or uncertain RB histology, but 0% in case of benign histology. The outcomes of the study were the rate of SUR avoided, the rate of Clavien–Dindo Grade specific complications avoided, and the net difference in per‐patient cost in Arm b‐RB relative to Arm a‐SUR. In all, 10 000 individual iterations of the simulation model were performed and among all iterations, the median and 95% confidence intervals were computed.Results: If a RB‐all strategy is implemented, the expected rate of SUR avoided is 6.7%. The rate of overall, Clavien–Dindo Grade >II, and Clavien–Dindo Grade >III complications avoided is 3.0%, 2.5%, and 0.5%, respectively, and the average net difference in per‐patient cost was −$840 (US dollars).Conclusions: The non‐selective use of RB in patients with a renal mass avoids a significant number of SUR, a marginal but existing number of complications, and is associated with decreased healthcare expenditures.


  • Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of clinical tumour size on postoperative renal function

    by G. Colandrea, D. Cignoli, G. Basile, G. Rosiello, G. Fallara, G. Baiamonte, F. Cei, C. Giancristofaro, G. Musso, D. Canibus, et al.